BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $307,814 | -18.4% | 8,156 | -1.5% | 0.01% | -8.3% |
Q2 2023 | $377,240 | +13.6% | 8,280 | +1.2% | 0.01% | 0.0% |
Q1 2023 | $331,978 | +13.9% | 8,185 | +43.1% | 0.01% | +9.1% |
Q4 2022 | $291,441 | +27.8% | 5,718 | +61.2% | 0.01% | +10.0% |
Q2 2022 | $228,000 | -1.3% | 3,547 | +10.6% | 0.01% | +11.1% |
Q1 2022 | $231,000 | -56.1% | 3,206 | -47.7% | 0.01% | -50.0% |
Q4 2021 | $526,000 | +10.0% | 6,128 | +3.1% | 0.02% | -5.3% |
Q3 2021 | $478,000 | +3.7% | 5,943 | +3.7% | 0.02% | +5.6% |
Q2 2021 | $461,000 | -3.4% | 5,730 | +1.2% | 0.02% | -14.3% |
Q1 2021 | $477,000 | +6.0% | 5,661 | +0.9% | 0.02% | 0.0% |
Q4 2020 | $450,000 | -1.1% | 5,608 | -0.9% | 0.02% | -16.0% |
Q3 2020 | $455,000 | -2.8% | 5,661 | +4.2% | 0.02% | -10.7% |
Q2 2020 | $468,000 | +6.1% | 5,431 | -0.1% | 0.03% | -15.2% |
Q1 2020 | $441,000 | +66.4% | 5,434 | +79.0% | 0.03% | +94.1% |
Q3 2019 | $265,000 | +3.5% | 3,035 | -3.0% | 0.02% | +6.2% |
Q2 2019 | $256,000 | +3.2% | 3,128 | +2.8% | 0.02% | 0.0% |
Q1 2019 | $248,000 | +22.8% | 3,044 | -0.8% | 0.02% | +14.3% |
Q4 2018 | $202,000 | -11.4% | 3,069 | +3.5% | 0.01% | 0.0% |
Q3 2018 | $228,000 | -13.0% | 2,964 | -20.8% | 0.01% | -46.2% |
Q2 2015 | $262,000 | -5.4% | 3,742 | -7.3% | 0.03% | -3.7% |
Q1 2015 | $277,000 | -6.4% | 4,038 | +0.1% | 0.03% | -10.0% |
Q4 2014 | $296,000 | -23.7% | 4,032 | -25.5% | 0.03% | -28.6% |
Q3 2014 | $388,000 | +4.3% | 5,409 | +5.1% | 0.04% | +5.0% |
Q2 2014 | $372,000 | -2.9% | 5,148 | -1.0% | 0.04% | -7.0% |
Q1 2014 | $383,000 | +21.6% | 5,201 | +14.9% | 0.04% | +16.2% |
Q4 2013 | $315,000 | +6.4% | 4,527 | +0.4% | 0.04% | -7.5% |
Q3 2013 | $296,000 | -5.1% | 4,511 | 0.0% | 0.04% | -16.7% |
Q2 2013 | $312,000 | – | 4,511 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |